GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Steep Hill Inc (XCNQ:STPH) » Definitions » Growth Rank

Steep Hill (XCNQ:STPH) Growth Rank : 0 (As of May. 25, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Steep Hill Growth Rank?

Steep Hill has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.


Steep Hill Growth Rank Related Terms

Thank you for viewing the detailed overview of Steep Hill's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Steep Hill (XCNQ:STPH) Business Description

Traded in Other Exchanges
N/A
Address
120 Adelaide Street West, Suite 2500, Toronto, ON, CAN, M5H 1T1
Steep Hill Inc is a science and technology health and wellness company focused on the hemp markets inclusive of plant-based, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) verticals. Currently the company, through its subsidiaries holds three industrial hemp licences for the purposes of supplying the global market with medicinal and wellness cannabidiol and other cannabinoid-based products.

Steep Hill (XCNQ:STPH) Headlines

No Headlines